Provided by Tiger Trade Technology Pte. Ltd.

LABORATORIOS FARMACEUTICOS ROVI SA

65.86
0.0000
Volume:- -
Turnover:- -
Market Cap:3.37B
PE:22.03
High:65.86
Open:65.86
Low:65.86
Close:65.86
52wk High:65.86
52wk Low:65.86
Shares:51.15M
Float Shares:18.61M
Volume Ratio:0.03
T/O Rate:- -
Dividend:1.11
Dividend Rate:1.68%
EPS(TTM):2.99
EPS(LYR):3.48
ROE:20.34%
ROA:10.46%
PB:4.58
PE(LYR):18.92

Loading ...

Company Profile

Company Name:
LABORATORIOS FARMACEUTICOS ROVI SA
Exchange:
PINK LIMITED
Establishment Date:
1946
Employees:
2197
Office Location:
Calle JosE Isbert, 2,Pozuelo de AlarcOn,Madrid,Madrid,Spain
Zip Code:
28223
Fax:
- -
Introduction:
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.